# Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study.

> PubMed lists PMID 30656523 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2019-01-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30656523-lixisenatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-01-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30656523-lixisenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30656523-lixisenatide-v1.json
- Content SHA-256: `7c55e127b6e1a556e871ebe9ede148225c7295f5503abe0dd89de0cce3487b7f`

## Claims and source pins

### Headline

Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study. ([`pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d`](#source-pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d))

### Summary

PubMed lists PMID 30656523 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2019-01-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d`](#source-pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d))

### Paragraph 1

PubMed lists PMID 30656523 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2019-01-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d`](#source-pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d`](#source-pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d))

## Sources

<a id="source-pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d"></a>
- **Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study. · retained source version 1:2021-01-09:current:12fd34f9e46dd89177530955d8da23046910dd009f9a9525fea7956ae10e9ab1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30656523/) (`pubmed-observation-pmid-30656523-2021-01-09-12fd34f9e46d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-30656523-lixisenatide-v1.json SHA-256: 7c55e127b6e1a556e871ebe9ede148225c7295f5503abe0dd89de0cce3487b7f.